Review
Copyright ©The Author(s) 2022.
World J Clin Oncol. Oct 24, 2022; 13(10): 762-778
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.762
Table 1 Gastrointestinal cancer data
Tissue
Incidence[1]
Mortality[1]
ASR incidence[1]
ASR mortality[1]
5-yr survival rate
Colorectum19315909351732.30.9460%-70.9%[1]
Esophagus6041005440760.780.6814.6%-23.2%[1]
Liver9056778301801.11.018%[3]
Pancreas4957734660030.550.517.9%-14.3%[1]
Gastric10891037687931.30.9020.8%-32.8%[1]
Table 2 Pathways enriched in transcriptional analyses in esophageal, gastric, liver, pancreas, and colorectal cancers
Pathway
CRC
EC
GC
HCC
PDAC
Ref.
Focal adhesionXXXXX[69-76]
ApoptosisXXXXX[71,72,77-79]
PAK pathwayXXXX[80-83]
PI3K/Akt signaling pathwayXXX[71,84-86]
TGF-beta pathwayXXXX[75,76,87-90]
Toll-like receptor signaling pathwayXXX[88,91-93]